Seres Therapeutics 8-K Filing: Key Insights from January 13, 2025
Based on the provided XML section of the financial report, here are the key insights and information extracted:
- Filing Information:
- Form Type: 8-K
- Filing Date: January 13, 2025
- Company Identifier (CIK): 0001609809
- Company Name: Seres Therapeutics, Inc.
- Company Details:
- State of Incorporation: Delaware (DE)
- SEC Central Index Key (CIK): 001-37465
- EIN (Employer Identification Number): 27-4326290
- Address: 101 Cambridgepark Drive, Cambridge, MA 02140
- Phone Number: (617) 945-9626
- Securities Information:
- Common Stock: Par value of $0.001 per share
- Stock Symbol: MCRB (traded on NASDAQ)
- Period of Report:
- Report Date: January 13, 2025
- This filing represents a single-day reporting period.
Insights:
- This report is an 8-K filing, which is typically used to report significant events that shareholders should know about. The specifics of what the event is were not provided in this excerpt.
- The company is publicly traded on NASDAQ under the symbol MCRB, which indicates it is subject to SEC regulations and reporting requirements.
- The report is for a specific date, indicating a potential important event or update that occurred on January 13, 2025.
Further analysis would require additional details on the contents of the 8-K filing to assess the implications of the reported event on the company’s financial position or market outlook.